Skip to main content

Advertisement

Log in

ASO Visual Abstract: Neoadjuvant Chemotherapy for Breast Cancer in the Elderly—Are We Accomplishing Our Treatment Goals?

  • ASO Visual Abstract
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrea V. Barrio MD.

Ethics declarations

Disclosures

This study was presented in podium/oral format at the Society of Surgical Oncology (SSO) 2022 International Conference on Surgical Cancer Care, Dallas, TX, March 9–12, 2022. The preparation of this study was supported in part by NIH/NCI Cancer Center Support Grant No. P30 CA008748 to Memorial Sloan Kettering Cancer Center. Dr. Monica Morrow has received honoraria from Exact Sciences and Roche. Dr. Chau Dang has research support from Roche-Genentech, PUMA, and Daiichi Sankyo, and has received honoraria from PUMA, Daiichi Sankyo, Pfizer, Novartis, and Evicore. All other authors have no conflict of interest disclosures to report.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Williams, A.D., Dang, C.T., Sevilimedu, V. et al. ASO Visual Abstract: Neoadjuvant Chemotherapy for Breast Cancer in the Elderly—Are We Accomplishing Our Treatment Goals?. Ann Surg Oncol 29, 8014–8015 (2022). https://doi.org/10.1245/s10434-022-12282-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-12282-w

Navigation